SEARCH

SEARCH BY CITATION

References

  • COX, B.M. (1999). Molecular and cellular mechanisms in opioid tolerance. In Towards a New Pharmacotherapy of Pain, eds. Bausbaum A.I. & Besson J.M. pp. 137156: John Wiley, Chichester, UK.
  • D'AMOUR, F.E. & SMITH, D.L. (1941). A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther., 72, 7479.
  • DENNIS, T., FOURNIER, A., CADIEUX, A., POMERLEAU, F., JOLICOEUR, F.B., ST & QUIRION, R. (1990). hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J. Pharmacol. Exp. Ther., 254, 123128.
  • DICKENSON, A.H. & SULLIVAN, A.F. (1986). Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn. Pain, 24, 211222.
  • DOODS, H., HALLERMAYER, G., WU, D., ENTZEROTH, M., RUDOLF, K, ENGEL W. & EBERLEIN, W. (2000). Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br. J. Pharmacol, 129, 420423.
  • DUNBAR, S. & YAKSH, T.L. (1996). Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the ra. [published erratum appears in Anesthesiology 1996 Sep; 85(3):695]. Anesthesiology, 84, 11771188.
  • ELLIOTT, K., HYNANSKY, A. & INTURRISI, C.E. (1994). Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain, 59, 361368.
  • GIBSON, S.J., POLAK, J.M., BLOOM, S.R., SABATE, I.M., MULDERRY, P.M., GHATEI, M.A., MCGREGOR, G.P., MORRISON, J.F., KELLY, J.S. & EVANS, R.M. (1984). Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J. Neurosci., 4, 31013111.
  • HUA, X.Y., CHEN, P., MARSALA, M. & YAKSH, T.L. (1999). Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids. Neurosci., 89, 525534.
  • JOHNSTON, P.A. & CHAHL, L.A. (1991). Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs. N.S. Arch. Pharmacol., 343, 283288.
  • KANGRGA, I., LAREW, J.S. & RANDIC, M. (1990). The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro. Neurosci. Lett., 108, 155160.
  • KOLESNIKOV, Y.A., PICK, C.G., CISZEWSKA, G. & PASTERNAK, G.W. (1993). Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. U.S.A., 90, 51625166.
  • KREEGER, J.S. & LARSON, A.A. (1993). Substance P-(1–7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice. Eur. J. Pharmacol., 238, 111115.
  • KURAISHI, Y. (1990). [Neuropeptide-mediated transmission of nociceptive information and its regulation. Novel mechanisms of analgesics]. [Japanese]. Yakugaku Zasshi, 110, 711726.
  • KURAISHI, Y., HIROTA, N., SATO, Y., HINO, Y., SATOH, M. & TAKAGI, H. (1985). Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn. Brain Res., 325, 294298.
  • LE REVES, P., NYBERG, F., TERENIUS, L. & HOKFELT, T. (1985). Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur. J. Pharmacol., 115, 309311.
  • LOOMIS, C.W., MILNE, B. & CERVENKO, F.W. (1987). Determination of cross tolerance in rat spinal cord using intrathecal infusion via sequential mini-osmotic pumps. Pharmacol. Biochem. Behav., 26, 131139.
  • MAO, J., PRICE, D.D. & MAYER, D.J. (1994). Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci., 14, 23012312.
  • MAO, J., PRICE, D.D. & MAYER, D.J. (1995a). Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain, 61, 353364.
  • MAO, J., PRICE, D.D. & MAYER, D.J. (1995b). Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain, 62, 259274.
  • MARRIOTT, D., WILKIN, G.P., COOTE, P.R. & WOOD, J.N. (1991). Eicosanoid synthesis by spinal cord astrocytes is evoked by substance P; possible implications for nociception and pain. Adv. Prostaglandin Thromboxane Leukotriene Res., 21B, 739741.
  • MATSUMURA, K., WATANABE, Y., IMAI-MATSUMURA, K., CONNOLLY, M., KOYAMA, Y. & ONOE, H. (1992). Mapping of prostaglandin E2 binding sites in rat brain using quantitative autoradiography. Brain Res., 581, 292298.
  • MENARD, D.P., VAN ROSSUM, D., KAR, S., JOLICOEUR, F.B., JHAMANDAS, K. & QUIRION, R. (1995). Tolerance to the antinociceptive properties of morphine in the rat spinal cord: alteration of calcitonin gene-related peptide-like immunostaining and receptor binding sites. J. Pharmacol. Exp. Ther., 273, 887894.
  • MENARD, D.P., VAN ROSSUM, D., KAR, S., ST PIERRE, S., SUTAK, M., JHAMANDAS, K. & QUIRION, R. (1996). A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. J. Neurosci., 16, 23422351.
  • MURASE, K., RYU, P.D. & RANDIC, M. (1989). Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons. Neurosci. Lett., 103, 5663.
  • NICOL, B., ROWBOTHAM, D.J. & LAMBERT, D.G. (1996). mu- and kappa-opioids inhibit K+ evoked glutamate release from rat cerebrocortical slices. Neurosci. Lett., 218, 7982.
  • OKU, R., SATOH, M., FUJII, N., OTAKA, A., YAJIMA, H. & TAKAGI, H. (1987). Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res., 403, 350354.
  • OWEN, J.A., MILNE, B., JHAMANDAS, K. & NAKATSU, K. (1981). Assembly of an inexpensive tail flick analgesia meter. J. Pharmacol. Meth., 6, 3337.
  • POHL, M., LOMBARD, M.C., BOURGOIN, S., CARAYON, A., BENOLIEL, J.J., MAUBORGNE, A., BESSON, J.M., HAMON, M. & CESSELIN, F. (1989). Opioid control of the in vitro release of calcitonin gene-related peptide from primary afferent fibres projecting in the rat cervical cord. Neuropeptides, 14, 151159.
  • POWELL, K.J., HOSOKAWA, A., BELL, A., SUTAK, M., MILNE, B., QUIRION, R. & JHAMANDAS, K. (1999). Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br. J. Pharmacol., 127, 631644.
  • QUIRION, R., MA, W., ZHENG, W.-H., KAR, S. (1999). Morphine induced calcitonin gene-related peptide increase in cultured dorsal root ganglion neurons. Soc. Neurosci., 25, 1434.
  • QUIRION, R., VAN ROSSUM, D., DUMONT, Y., ST-PIERRE, S. & FOURNIER, A. (1992). Characterization of CGRP1 and CGRP2 receptor subtypes. Ann. N. Y. Acad. Sci., 657, 88105.
  • REKIK, M., DELVAUX, M., FREXINOS, J. & BUENO, L. (1997). The calcitonin gene-related peptide activates both cAMP and NO pathways to induce relaxation of circular smooth muscle cells of guinea-pig ileum. Peptides, 18, 15171522.
  • SALT, T.E. & HILL, R.G. (1983). Pharmacological differentiation between responses of rat medullary dorsal horn neurons to noxious mechanical and noxious thermal cutaneous stimuli. Brain Res., 263, 167171.
  • SHARMA, S.K., KLEE, W.A. & NIRENBERG, M. (1975). Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U.S.A., 72, 30923096.
  • SHIMOYAMA, N., SHIMOYAMA, M., INTURRISI, C.E. & ELLIOTT, K.J. (1996). Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology, 85, 13571366.
  • TAYLOR, G.M., MEERAN, K., O'SHEA, D., SMITH, D.M., GHATEI, M.A. & BLOOM, S.R. (1996). Adrenomedullin inhibits feeding in the rat by a mechanism involving calcitonin gene-related peptide receptors. Endocrinology, 137, 32603264.
  • TISEO, P.J. & INTURRISI, C.E. (1993). Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther., 264, 10901096.
  • TRAFTON, J.A., ABBADIE, C., MARCHAND, S., MANTYH, P.W. & BASBAUM, A.I. (1999). Spinal opioid analgesia: How critical is the regulation of substance P signalling J. Neurosci., 19, 96429653.
  • TRUJILLO, K.A. & AKIL, H. (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 251, 8587.
  • TRUJILLO, K.A. & AKIL, H. (1994). Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res., 633, 178188.
  • VAN ROSSUM, D., HANISCH, U.K. & QUIRION, R. (1997). Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci. Biobehav. Rev., 21, 649678.
  • VASKO, M.R., CAMPBELL, W.B. & WAITE, K.J. (1994). Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J. Neurosci., 14, 49874997.
  • WELCH, S.P., SINGHA, A.K. & DEWEY, W.L. (1989). The antinociception produced by intrathecal morphine, calcium, A23187, U50, 488H, [D-Ala2, N-Me-Phe4, Glyol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice. J. Pharmacol. Exp. Ther., 251, 18.
  • WIESENFELD-HALLIN, Z., HOKFELT, T., LUNDBERG, J.M., FORSSMANN, W.G., REINECKE, M., TSCHOPP, F.A. & FISCHER, J.A. (1984). Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat. Neurosci. Lett., 52, 199204.
  • WIMALAWANSA, S.J. (1996). Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocrine Rev., 17, 533585.
  • XU, X.J. & WIESENFELD-HALLIN, Z. (1991). The threshold for the depressive effect of intrathecal morphine on the spinal nociceptive flexor reflex is increased during autotomy after sciatic nerve section in rats. Pain, 46, 223229.
  • YASKH, T.L. & RUDY, T.A. (1976). Chronic catheterization of the subarachnoid space. Physiol. Behav., 7, 10321036.
  • YAKSH, T.L., JESSELL, T.M., GAMSE, R., MUDGE, A.W. & LEEMAN, S.E. (1980). Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature, 286, 155157.
  • YASHPAL, K., KAR, S., DENNIS, T. & QUIRION, R. (1992). Quantitative autoradiographic distribution of calcitonin gene-related peptide (hCGRP alpha) binding sites in the rat and monkey spinal cord. J. Comp. Neurol., 322, 224232.
  • YE, Z., WIMALAWANSA, S.J. & WESTLUND, K.N. (1999). Receptor for calcitonin gene-related peptide: localization in the dorsal and ventral spinal cord. Neurosci., 92, 13891397.
  • YU, L.C., HANSSON, P. & LUNDEBERG, T. (1994). The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses in rat. [published erratum appears in Brain Res 1994 Dec 15;666(2):295]. Brain Res., 653, 223230.